Hypersensitivity  >>  mometasone furoate nasal spray  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mometasone furoate nasal spray / Generic mfg.
NCT02113267 / 2012-005842-39: Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.

Terminated
2
40
Europe
Mometasone furoate, Nasonex, Placebo, Nasonex comparator spray (APL)
Mogens Bove, Vastra Gotaland Region
Eosinophilic Esophagitis
09/18
09/18
NCT01523236: Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Completed
1/2
800
US
Mometasone furoate, Nasonex®, Mometasone furoate (generic name), Placebo
Teva Pharmaceuticals USA
Seasonal Allergic Rhinitis
01/12
01/12

Download Options